Our Bioinformatics, Biostatistics & Software Development team capabilities complement our wet lab operations in every aspect of supporting biomarker programs, as well as providing stand-alone technical services.
At each stage of development or delivery of a biomarker, we have established dry lab processes in place to maximize the successful development & delivery of the clinical trial assay (RUO, IUO or CDx). Analysis is standardized and repeatable, and rigorously tested & validated in accordance with regulatory standards.
The team spans three regions (UK, EU and USA) and is comprised of highly experienced scientific experts
Our range of services:
Click each link below to find out more information about our Bioinformatics, Biostatistics and Software Development capabilities:
Almac proprietary analysis tools for better client data insights:
Almac Diagnostic Services also invests R&D time into proprietary bioinformatics products to enhance the data output of both DNA and RNA sequencing and analysis for biomarker discovery.
Benefits of Almac Data Sciences approach:
Having these capabilities available all in one location, through an experienced service provider means a more efficient and streamlined service for clients transitioning a clinical assay from the initial discovery phase through to clinical delivery.
Each stage of the process is designed to ensure subsequent stages are entered into with minimal risks and obstacles.